Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-19 POST LEONARD E Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-19 Jacques Rachelle Suzanne Director Grant or award +8,080 22,488
2024-06-19 Jacques Rachelle Suzanne Director Grant or award · Stock Option (Right to Buy) +15,840 15,840
2024-06-17 CALOZ PIERRE Chief Operating Officer Sale −2,936 $4.81 $14K 115,707
2024-06-17 KLEMT CHRISTIAN Chief Financial Officer Sale −1,611 $4.80 $8K 164,837
2024-06-13 POST LEONARD E Director Sale −2,222 $5.14 $11K 15,999
2024-06-13 Potts Jeannette Chief Legal Officer Sale −4,781 $4.98 $24K 91,819
2024-06-13 Springhorn Jeremy P. Director Sale −2,231 $5.12 $11K 23,756
2024-06-13 Meek David D. Director Sale −2,229 $5.12 $11K 20,252
2024-06-13 Balachandran Madhavan Director Sale −2,231 $5.12 $11K 23,759
2024-06-13 Soteropoulos Paula Director Sale −2,220 $5.14 $11K 20,203
2024-06-13 Gut Robert Director Sale −3,504 $5.12 $18K 44,165
2024-06-13 Kaye Jack Director Sale −2,218 $5.16 $11K 6,501
2024-06-13 Jacques Rachelle Suzanne Director Sale −2,221 $5.14 $11K 14,408
2024-03-01 Kapusta Matthew C CEO, Managing Director Grant or award +150,000 590,839
2024-03-01 Kapusta Matthew C CEO, Managing Director Grant or award · Stock Option (Right to Buy) +259,500 259,500
2024-03-01 KLEMT CHRISTIAN Chief Financial Officer Grant or award +49,500 166,448
2024-03-01 KLEMT CHRISTIAN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +85,500 85,500
2024-03-01 Abi-Saab Walid Chief Medical Officer Grant or award +49,500 116,700
2024-03-01 Abi-Saab Walid Chief Medical Officer Grant or award · Stock Option (Right to Buy) +85,500 85,500

Page 11 of 13 · 251 trades